Last reviewed · How we verify

NCT03352570: SAFE-1

a Study to Investigate the Efficacy, and Safety of the Colovac Colorectal Anastomosis Protection Device.

Completed NA Last updated 10 October 2019
What this trial tests

NA trial testing COLOVAC in Gastrointestinal Anastomotic Complication in 15 participants. Completed in 26 March 2019.

Timeline
14 November 2017
Primary endpoint
26 September 2018
26 March 2019

Quick facts

Lead sponsorSafeheal
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment15
Start date14 November 2017
Primary completion26 September 2018
Estimated completion26 March 2019
Sites3 locations across Belgium, France

Drugs / interventions tested

Conditions studied

Sponsor

Safeheal

Who can join

Adults 18 to 65, any sex, with Gastrointestinal Anastomotic Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate theColovac device, a single use, temporary intraluminal bypass device,intended to reduce contact of fecal content with an anastomotic site, following colorectal surgery (open or laparoscopic).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Advanced innovations in reducing anastomotic leak: a review of emerging biomaterial applications in colorectal surgery.
    Chen E, Chen L, Zhang W, Zhou W. · · 2025 · PMID 41051406 · DOI 10.1007/s00384-025-04930-w

Verify or expand the search:

Other Safeheal trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03352570.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing